"The voice of oncology in Massachusetts." |
Full Prescription Product List
AbbVie is committed to helping patients get the medicines they need. That’s why we offer patient assistance programs that provide free AbbVie medicines to qualifying patients. Our Patient Assistance Programs are intended for people that live in the United States, have limited or no health insurance coverage and demonstrate qualifying financial need.
Contact: 1-800-222-6885
Program Info: myAbbVie Assist
PYRUKYND® (mitapivat) tablets
MyAgios Patient Support Services is a customized support program for people living with pyruvate kinase (PK) deficiency.
Contact: Nefar Moran, Patient Support Manager (800-951-3889)
Program Info: MyAgios Patient Support Services
Amgen® SupportPlus provides access support and helpful resources across Amgen® therapies.
Program Info: amgensupportplus.com
AmBisome (amphotericin B), CRESEMBA (isavuconazonium sulfate), Luxiscan (regadenoson), Myrbetriq (mirabegron), PADCEV (enfortumab vedotin-ejfv), XOSPATA (gilteritinib), Xtandi (enzalutamide)
Astellas Pharma Support Solutions offers access and reimbursement support to help patients overcome challenges to accessing Astellas products.
Program Info: Astellas Pharma Support Solutions
Full Prescription Product List
At AstraZeneca, we believe it’s not enough for us to simply make medicines. We have to make sure that the people who need those medicines can get them. It’s why we’ve offered patient assistance programs for over 30 years. The program provides personal support to help streamline access and reimbursement for select AstraZeneca medicines. Access 360 provides:
The AstraZeneca AZ&ME Prescription Savings Program is helping patients who are having trouble affording their AstraZeneca medicines. This site will guide you through the AZ&Me application process to see if you are eligible for the program.
Contact: 1-800-AZandME
Program Info: AstraZeneca Access 360
FOTIVDA® (tivozanib)
Visit the website for more information on Aveo’s Patient Support Programs.
Contact: 1-833-FOTIVDA (1-833-368-4832)
Program Info: Aveo Ace Program
BRUKINSA® (zanubrutinib)
The myBeiGene BRUKINSA® patient support program can provide you with reimbursement and payment assistance to help you gain access to Brukinsa. Please see full Prescribing Information including Patient Information.
Call 1-833-BEIGENE (1-833-234-4363). Oncology Nurse Advocates are available Monday through Friday from 8 AM to 8 PM Eastern Time (ET)
Program Info: myBeiGene Patient Support
AYVAKIT® (avapritinib)
Visit the website to learn more about Blueprint Medicine’s patient support program, YourBlueprint. This website provides information about access and reimbursement, financial assistance, how to order your patient’s prescribed drug, and helpful resources.
Program Info: YourBlueprint
Full Prescription Product List
Bristol-Myers Squibb is committed to helping appropriate patients get access to our medications by providing access and reimbursement services.
Contact: 1-800-861-0048
Program Info: BMS Access Support
VONJO™ (pacritinib)
CTI BioPharma Corp. is committed to helping patients, caregivers, and healthcare professionals access VONJO™ (pacritinib) and the support they need. Available Monday through Friday between 8 am and 8 pm EST at 888‑CTI‑FORU (888‑284‑3678).
Program Info: ctiaccess.com
ENHERTU4U (fam-trastuzumab deruxtecan-nxki), injectafer (ferric carboxymaltos), Turalio (pexidartinib)
Access Central is committed to helping you get the Daiichi Sankyo medication you need and is an important resource for you and your doctor. We provide support tailored to your unique needs, including:
Contact: 1-866- 4-DSI-NOW (1-866-437-4669)
Program Info: DAIICHI SANKYO ACCESS CENTRAL
LENVIMA® (lenvatinib) and HALAVEN® (eribulin mesylate)
At Eisai, everything we do is guided by a simple principle: patients and their families come first and we have a responsibility to listen to and learn from them.
We call this human health care, or hhc.
For program and eligibility information, and to review the program terms and conditions, call 1-866-61-EISAI (1-866-613-4724) or visit eisaireimbursement.com.
CABOMETYX® (cabozantinib)
Exelixis Access Services (EASE)
Access. Assistance. Along The Journey.
Exelixis Access Services® (EASE) provides a variety of support to help your patients start treatment quickly. EASE can help meet the unique needs of your patients and practice at each step along the access journey.
Questions? Contact - Michele Sofarelli Luther - msofarelli@exelixis.com
Program Info: www.ease.us
Full Prescription Product List
Genentech is dedicated to helping patients. Since Genentech started providing access and reimbursement support almost 20 years ago, Genentech has helped more than 2 million patients access the medicines they need.
TRODELVY® (sacituzumab govitecan-hziy)
TRODELVY ACCESS SUPPORT is a patient access and reimbursement support program.
Please click to see full Prescribing Information, including BOXED WARNING.
ZEJULA (niraparib), JEMPERLI (dostarlimab-gxly)
Together with GSK Oncology. At GSK, we understand that a cancer diagnosis can be overwhelming for patients and loved ones. Treatment considerations and costs can add undue stress, especially if you’re unsure what coverage options are available or how to access them. Together with GSK Oncology is here to help, offering patients and healthcare professionals a variety of access and reimbursement services for all GSK oncology products—all in one place.
Program Info: www.togetherwithgskoncology.com
Jakafi® (ruxolitinib) and Pemazyre (pemigatinib)
Visit the website for more information on Incyte's Patient Support Programs.
Program Info: http://www.IncyteCares.com
Full Prescription Product List
Janssen Compass Info: https://www.janssencompass.com/
Janssen's Advocacy Connector: http://advocacyconnector.com. Advocacy organizations offer a range of different services, including financial support or transportation services. They may even be able to help you in ways you never expected. Use this tool to find organizations near you that can help.
JazzCares provides access and reimbursement support to Jazz medications. See the downloadable handout for information.
Contact: 1-833-533-JAZZ (5299)
Program Info: Jazzcares.com
XPOVIO® (selinexor)
KaryForward can assist with access and insurance coverage, financial assistance, and nurse care manager support. KaryForward is here to help you every step of the way — from insurance coverage and financial assistance to support and resources — so you can focus on moving forward with your life.
Contact: 1-877-KARY4WD (1-877-527-9493)
Program Info: KaryForward.com
ALIMTA® (pemetrexed), CYRAMZA® (ramucirumab), ERBITUX® (cetuximab), Portrazza® (necitumumab), Retevmo® (selpercatinib), Verzenio® (abemaciclib)
Lilly is dedicated to developing treatments, but we're more than just our medicines. We’re determined to do our part to help patients and their loved ones. Through the Lilly Oncology Support Center, we strive to offer personalized treatment support for eligible patients prescribed a Lilly Oncology product.
Contact: 1-866-472-8663
Program Info: Lilly Oncology Support Center
KEYTRUDA® (pembrolizumab)
The Merck Access Program is here to help answer your questions about insurance and coverage after you have been prescribed KEYTRUDA by your healthcare provider. The Merck Access Program provides information and resources that you may find helpful.
Program Info: merckaccessprogram-keytruda.com or call 855-257-3932
Patient Support: The KEY+YOU program is designed for patients prescribed KEYTRUDA for an approved indication. Educational resources are provided to patients and caregivers to help you understand your treatment with KEYTRUDA and be more active and vocal in your or your loved one’s care.
KRAZATI® (adagrasib)
The Mirati & Me Patient Support Program offers comprehensive support services for eligible patients, caregivers, and healthcare professionals, including personalized education and financial resources to help patients who have been prescribed Mirati medications start and stay on treatment.
Program Info: Mirati & Me
KRAZATI Savings Card: www.krazatisavingscard.com
An online enrollment option, Pfizer PAP Connect, was recently introduced for many of our most commonly requested primary care medications available through the Pfizer Patient Assistance Program. Now, for certain primary care medicines, eligible new and re-enrolling patients and their HCPs can start and complete enrollment process online through Pfizer PAP Connect. To learn more, please go to www.PfizerPAPConnect.com.
To learn more about Pfizer assistance options, eligibility requirements, and terms and conditions that apply, visit www.PfizerRxPathways.com or call the toll-free phone number 1-844-989-PATH (7284) to consult with a Pfizer Medicine Access Counselor.
Pfizer Oncology TogetherTM is a program that offers you personalized support. We’ll help you find resources for financial assistance and other day-to-day challenges you may be facing. Because when it comes to support, we’re in this together.
IMBRUVICA® (ibrutinib)
By Your Side* is a patient program designed specifically to support IMBRUVICA® (ibrutinib) prescribed patients.
Prescribing Information: www.rxabbvie.com/pdf/imbruvica_pi.pdf
Program Info: ByYourSideHCP.com
LIBTAYO Surround Patient Support Program can help patients access LIBTAYO® (cemiplimab-rwlc) and navigate the health insurance process. It provides:
For more information, call LIBTAYO Surround at 1.877.LIBTAYO (1.877.542.8296) Option 1, Monday–Friday 8:00 AM–8:00 PM Eastern time.
Program Information: LIBTAYO Surround
TAVALISSE® (fostamatinib disodium hexahydrate)
RIGEL ONECARE is a patient support center whose nurse navigators provide support for patients prescribed TAVALISSE (fostamatinib disodium hexahydrate) tablets.
Contact RIGEL ONECARE at 833-744-3562 for more information about specific programs.
> Patient Assistance Program Form
Program Information: RIGEL ONCECARE
Seagen Secure® was designed specifically to support patients and professional! You or a caregiver may have questions when beginning a new therapy—most people do. Seagen Secure® is your all-in-one resource that's dedicated to supporting you in accessing your prescribed treatment with ADCETRIS® (brentuximab vedotin), Tivdak® (tisotumab vedotin-tftv), or TUKYSA® (tucatinib).
Program Information: seagensecure.com
ServierONE.com is your all-in-one resource for help with the cost of treatment, determining insurance coverage, one-on-one support, and access to additional resources and educational tools.
Email: PatientServices@servier.com
Program Information: ServierONE.com
Stemline ARC® provides access support, reimbursement assistance and educational resources to help patients and the healthcare professionals involved in their care, so patients can focus on what matters most—their health. Connect with a Stemline ARC Patient Advocate at 1-833-4-STEMLINE (1-833-478-3654), 9:00 AM to 6:00 PM ET, Monday through Friday, to learn more.
Program information: stemlinearc.com
Takeda Oncology Here2Assist® is a comprehensive support program committed to helping patients navigate coverage requirements, identify available financial assistance, and connect with helpful resources throughout their Takeda Oncology treatment.
Program Information: Here2assist.com
Co-Pay AssistanceACCC Patient Assistance and Reimbursement GuideACCC Patient Assistance and Reimbursement Guide is available online and in print FREE to ACCC members. Expanded and updated, ACCC's Patient Assistance and Reimbursement Guide features a quick reference guide by drug name with links directly to the drug manufacturers. More information. Cancercare co-payment assistance foundationThe CancerCare Co-Payment Assistance Foundation is a not-for-profit organization established in 2007 to address the needs of individuals who cannot afford their insurance co-payments to cover the cost of medications for treating cancer. More information. Family ReachFamily Reach is a national nonprofit dedicated to alleviating the financial burden of cancer. Working with more than 400 top-tier hospitals and cancer centers nationwide, they provide immediate financial assistance, education and navigation to families before they hit critical breaking points. Their efficient, solutions-driven model bridges the gap between hospital and home, quickly providing the vital support families need to stay afloat. More information. Pharmaceutical Research and Manufacturers of America (PhRMA)They created the Medicine Assistance Tool (MAT) to provide a dedicated search engine that allows users to search for financial assistance resources available to them, their loved ones or patients in their lives through the various biopharmaceutical industry programs available for patients who are eligible. More information. PAN FoundationThe Patient Access Network (PAN) Foundation is an independent, national 501 (c)(3) organization dedicated to helping federally and commercially insured people living with life-threatening, chronic and rare diseases with the out-of-pocket costs for their prescribed medications. Partnering with generous donors, healthcare providers and pharmacies, PAN provides the underinsured population access to the healthcare treatments they need to best manage their conditions and focus on improving their quality of life. More information. PAF Co-Pay Relief ProgramThe Patient Advocate Foundation (PAF) Co-Pay Relief Program (CPR) currently provides direct financial support to insured patients, including Medicare Part D beneficiaries, who must financially and medically qualify to access pharmaceutical co-payment assistance. The program offers personal service to all patients through the use of call counselors; personally guiding patients through the enrollment process. More information. Patient Services IncorporatedPSI is the "ground breaking" 501(c)(3) non-profit, charitable organization of its kind. For nearly two decades, PSI has helped people who live with certain chronic illnesses or conditions locate suitable health insurance coverage and access ways to satisfy expensive co-payments. PSI provides assistance with the cost of health insurance premiums associated with COBRAs, State High Risk Pools, Open enrollment, Guaranteed Issue policies, HIPAA conversion policies; and prescriptions co-payments associated with private insurance as well as with Medicare Parts B and D. More Information. |